Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial

Piet Ost, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, Fernando López Campos, Alexandros Papachristofilou, Matthias Guckenberger, Marta Scorsetti, Almudena Zapatero, Ana-Elena Villafranca Iturre, Clara Eito, Felipe Couñago, Paolo Muto, Wim Duthoy, Nicolas Mach, Valérie Fonteyne, Daniel Moon, Kristian Thon, Carole Mercier, Vérane Achard, Karin Stellamans, Els Goetghebeur, Dries Reynders, Thomas Zilli

Open source

DOI: 10.1016/s1470-2045(25)00197-4
Published: 2025-06
Container: The Lancet Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-25-00197-4,
  title = {Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial},
  author = {Piet Ost and Shankar Siva and Sigmund Brabrand and Piet Dirix and Nick Liefhooghe and François-Xavier Otte and Alfonso Gomez-Iturriaga and Wouter Everaerts and Mohamed Shelan and Antonio Conde-Moreno and Fernando López Campos and Alexandros Papachristofilou and Matthias Guckenberger and Marta Scorsetti and Almudena Zapatero and Ana-Elena Villafranca Iturre and Clara Eito and Felipe Couñago and Paolo Muto and Wim Duthoy and Nicolas Mach and Valérie Fonteyne and Daniel Moon and Kristian Thon and Carole Mercier and Vérane Achard and Karin Stellamans and Els Goetghebeur and Dries Reynders and Thomas Zilli},
  year = {2025},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(25)00197-4},
  url = {https://doi.org/10.1016/s1470-2045(25)00197-4}
}

RIS

TY  - JOUR
TI  - Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial
AU  - Piet Ost
AU  - Shankar Siva
AU  - Sigmund Brabrand
AU  - Piet Dirix
AU  - Nick Liefhooghe
AU  - François-Xavier Otte
AU  - Alfonso Gomez-Iturriaga
AU  - Wouter Everaerts
AU  - Mohamed Shelan
AU  - Antonio Conde-Moreno
AU  - Fernando López Campos
AU  - Alexandros Papachristofilou
AU  - Matthias Guckenberger
AU  - Marta Scorsetti
AU  - Almudena Zapatero
AU  - Ana-Elena Villafranca Iturre
AU  - Clara Eito
AU  - Felipe Couñago
AU  - Paolo Muto
AU  - Wim Duthoy
AU  - Nicolas Mach
AU  - Valérie Fonteyne
AU  - Daniel Moon
AU  - Kristian Thon
AU  - Carole Mercier
AU  - Vérane Achard
AU  - Karin Stellamans
AU  - Els Goetghebeur
AU  - Dries Reynders
AU  - Thomas Zilli
PY  - 2025
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(25)00197-4
UR  - https://doi.org/10.1016/s1470-2045(25)00197-4
ER  -

APA

Ost, P., Siva, S., Brabrand, S., Dirix, P., Liefhooghe, N., Otte, F., Gomez-Iturriaga, A., Everaerts, W., Shelan, M., Conde-Moreno, A., Campos, F. L., Papachristofilou, A., Guckenberger, M., Scorsetti, M., Zapatero, A., Iturre, A. V., Eito, C., Couñago, F., Muto, P., Duthoy, W., Mach, N., Fonteyne, V., Moon, D., Thon, K., Mercier, C., Achard, V., Stellamans, K., Goetghebeur, E., Reynders, D., & Zilli, T. (2025). Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(25)00197-4

Source records

crossref · retrieved 2026-09-26T13:16:00.009Z